CacheBy
Thermo Fisher Scientific NKX2.2 Monoclonal Antibody (ZM14), MonoMab
원본

Thermo Fisher Scientific NKX2.2 Monoclonal Antibody (ZM14), MonoMab

상품 한눈에 보기

Ready-to-use monoclonal antibody for IHC detection of NKX2.2 in formalin-fixed, paraffin-embedded tissues. Highly specific marker for Ewing sarcoma and neuroendocrine tumors. Mouse IgG1 clone ZM14, unconjugated form, stored at 4°C.

판매단위
pk
카탈로그 보기

카탈로그

1개 옵션
회원가입 없이 바로 구매하세요
가입하지 않아도 비회원가로 구매하실 수 있습니다.
ADBIX 2026 전시회10/28~30 코엑스 · 사전등록 안내자세히보기
Thermo Fisher Scientific Z2348MP NKX2.2 Monoclonal Antibody (ZM14), MonoMab 7 mL pk판매 단위 pk
재고 확인 필요
373,500원VAT 포함 410,850원

Thermo Fisher Scientific · Thermo Fisher Scientific NKX2.2 Monoclonal Antibody (ZM14), MonoMab

Applications

  • Immunohistochemistry (Paraffin) (IHC (P))

Tested Dilution

Ready-to-use (150–200 µL)


Product Specifications

항목 내용
Species Reactivity Human
Host / Isotype Mouse / IgG1, kappa
Class Monoclonal
Type Antibody
Clone ZM14
Immunogen Human recombinant NKX2.2 protein fragment (aa 1–119)
Conjugate Unconjugated
Form Liquid
Purification Protein A
Storage buffer Tris with BSA, NP-40
Contains <0.1% sodium azide
Storage conditions 4°C
Shipping conditions Wet ice

Product Specific Information

This product is diluted and ready-to-use.
A recommended positive control tissue is Ewing’s sarcoma, though other positive controls may be used.

The antibody is intended for professional laboratory use in detecting NKX2.2 protein in formalin-fixed, paraffin-embedded tissue through manual qualitative immunohistochemistry (IHC). It is used after the primary diagnosis of tumor by conventional histopathology.

NKX2.2 expression is observed in neuroendocrine tumors of the gut and serves as a marker for gastrointestinal neuroendocrine tumors. It is also a target of the EWS-FLI-1 fusion protein specific to Ewing sarcoma, showing 93% sensitivity and 89% specificity, aiding in differential diagnosis of small round cell tumors.

Pretreatment of deparaffinized tissue with heat-induced or enzymatic epitope retrieval is recommended.
IHC staining involves sequential application of primary antibody, secondary antibody, enzyme complex, and chromogenic substrate, with washing steps between applications. The chromogen reaction produces visible staining at the antigen site, interpreted under a light microscope.

A positive tissue control must be included in each staining procedure. This control should contain both positive and negative staining regions and be processed identically to patient samples. Weak positive controls are preferred for detecting minor changes in antibody sensitivity or reagent stability.

Negative control tissue may be internal or external depending on institutional guidelines. Negative sites should show absence of specific staining, ensuring minimal background signal. If specific staining appears in negative controls, patient results are invalid.


Target Information

The NKX2.2 gene encodes a nuclear transcription factor containing a homeobox domain, involved in central nervous system morphogenesis. It is located on chromosome 20 near NKX2-4 and duplicated on chromosome 14 as TITF1 and NKX2-8.


For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

제품 이미지

Thermo Fisher Scientific 상품 둘러보기

전체보기

문의

0개

아직 등록된 문의가 없어요.